What is the clinical evidence from this study?

Study design: Other. Population: Adriamycin-induced cardiomyopathy. Intervention: Probucol vs. Adriamycin alone / control. Primary outcome: Antioxidant enzyme gene expression and heart failure.

What question did this study set out to answer?

The study aims to evaluate how probucol affects antioxidant enzyme gene expression during adriamycin-induced cardiomyopathy in rats.

June 1, 2000Cardiovascular ResearchOpen Access

Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats

View Full Paper

Ask AI

Bookmark

Key result

Probucol prevented adriamycin-induced heart failure and the associated 45% and 20% depression in MnSOD mRNA and protein levels in a rat model.

Authors

TLT LiUniversity of Dundee

Discussion

Member takes

Implication

Should not alter adriamycin management; leaves open probucol's MnSOD effects for human translation.

Key Points

The study aims to evaluate how probucol affects antioxidant enzyme gene expression during adriamycin-induced cardiomyopathy in rats.
Examined mRNA and protein levels of antioxidant enzymes using Northern and Western blotting techniques.
Compared enzyme activities in control and probucol-treated rats over a three-week period.
Assessed oxidative stress through TBARS measurement.
Adriamycin (ADR) caused heart failure, which was prevented by probucol.
MnSOD mRNA and protein levels decreased by 45% and 20% respectively due to ADR; probucol counteracted these effects.
While GSHPx activity decreased and oxidative stress increased with ADR, probucol treatment mitigated these changes.

PICO

Population

Rat model of adriamycin-induced cardiomyopathy followed for 3 weeks.

Intervention / Comparator

Probucol vs Adriamycin alone / control

Primary Outcome

Antioxidant enzyme gene expression and heart failure

Cite This Study

T Li (2000) studied Adriamycin-induced cardiomyopathy. Probucol vs. Adriamycin alone / control was evaluated on Antioxidant enzyme gene expression and heart failure. Probucol prevented adriamycin-induced heart failure and the associated 45% and 20% depression in MnSOD mRNA and protein levels in a rat model.

synapsesocial.com/papers/6a6eb6c035aa2c282ce05f0d https://doi.org/10.1016/s0008-6363(00)00039-0

Topics

HFrEF treatment Heart failure

View Full Paper

Ask AI

Bookmark

Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Topics

Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Also Consider

Topics

Also Consider